netFormulary NHS
Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust
 Search
 Formulary Chapter 11: Eye - Full Chapter
Notes:

Joint guidance

Number of drops per bottle

Bottle size Approximate number of drops contained
2.5ml 50 drops
5ml 100 drops
10ml 200 drops

Prescribing

Unless specifically stated on the fomrulary, all medicines should be prescribed generically irrespective of brands that may be avaiable.

Adminstration aids

If patient has difficulty administering eye drops, consider co-prescribing an Opticare eye drop dispenser

Supplements

Unlicensed food supplements such as I-Caps®; etc. for age related macular degeneration should not be prescribed on the NHS.

 Details...
11.99.99.99  Expand sub section  Miscellaneous
11.99.99.99  Expand sub section  Antifungals
11.99.99.99  Expand sub section  Cytotoxics / wound healing modulators
Aflibercept 40mg/ml (Eylea®)
(intravitreal injection )
View adult BNF View SPC online View childrens BNF
Formulary
Red Hospital
High Cost Medicine
BlueTeq
 
Link  NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration
Link  NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
Link  NICE TA346:Aflibercept for treating diabetic macular oedema
Link  NICE TA409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion
Link  NICE TA486: Aflibercept for treating choroidal neovascularisation
   
Brolucizumab 19.8/0.165ml solution for intravitreal injectionBlack Triangle (Beovu®)
(Pre-filled syringe)
View adult BNF View SPC online View childrens BNF
Formulary
Red Hospital
High Cost Medicine
CCG
BlueTeq
 
Link  NICE TA672 Brolucizumab for treating wet age-related macular degeneration
   
Dexamethasone 700mcg (Ozurdex®)
(intravitreal implant)
View adult BNF View SPC online View childrens BNF
Formulary
Red Hospital
High Cost Medicine
BlueTeq
 
Link  NICE TA229: Treatment of macular oedema secondary to retinal vein occlusion
Link  NICE TA349: Diabetic Macular Oedema
   
Fluocinolone 190mcg/ml (Iluvien®)
(intravitreal implant)
View adult BNF View SPC online View childrens BNF
Formulary
Red Hospital
High Cost Medicine
BlueTeq
 
Link  NICE TA301: Treating chronic diabetic macular oedema after an inadequate response to prior therapy
Link  NICE TA590 Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis
   
Ocriplasmin 0.5mg/0.2ml  (Jetrea®)
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Red Hospital
High Cost Medicine
BlueTeq
 
Link  NICE TA297: Ocriplasmin for treating vitreomacular traction
   
Ranibizumab 10mg/ml (Lucentis®)
(intravitreal injection )
View adult BNF View SPC online View childrens BNF
Formulary
Red Hospital
High Cost Medicine
BlueTeq
 
Link  NICE TA155: Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Link  NICE TA274:Ranibizumab for treating diabetic macular oedema
Link  NICE TA283: Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion
Link  NICE TA298:Ranibizumab for treating choroidal neovascularisation associated with pathological myopia
   
11.99.99.99  Expand sub section  Fibrinolytic drugs
11.99.99.99  Expand sub section  Glues - ocular to top
11.99.99.99  Expand sub section  Immunosuppressants
11.99.99.99  Expand sub section  Treatment of burns
11.99.99.99  Expand sub section  Visco-elastics
11.99.99.99  Expand sub section  Other
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Blue

For routine prescribing in primary and secondary care.   

Green

Initiated (if clinically urgent) or advised (if non-urgent) by specialist in secondary care, prescribing can be continued in primary care.   

Amber

Shared care  

Red Hospital

Hospital only  

Double Red

There should be no prescribing of these drugs  

Mixed

The traffic light of the drug is dependant on the indication. Please see individual drug entry for details  

netFormulary